China SXT Pharmaceuticals Inc Net Asset Quality Index
China SXT Pharmaceuticals Inc net asset quality index. China SXT Pharmaceuticals Inc (SXTC) has a Net Asset Quality Index of 85.5% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $34.75 Million minus total liabilities of $5.05 Million yields net assets of $29.71 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check China SXT Pharmaceuticals Inc (SXTC) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of China SXT Pharmaceuticals Inc (2016–2026)
Net asset quality index of China SXT Pharmaceuticals Inc from 2016 to 2026. This chart shows how China SXT Pharmaceuticals Inc's Net Asset Quality Index has evolved across 11 annual periods from 2016 to 2026. As of June 2026, the index stands at 85.5%, representing net assets of $29.71 Million against total assets of $34.75 Million USD. See China SXT Pharmaceuticals Inc (SXTC) shareholders funds for net asset value and shareholders' equity analysis.
China SXT Pharmaceuticals Inc Net Asset Quality Index by Year (2016–2026)
China SXT Pharmaceuticals Inc net asset quality index by year from 2016 to 2026. The table below presents the year-by-year Net Asset Quality Index for China SXT Pharmaceuticals Inc from 2016 to 2026, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see China SXT Pharmaceuticals Inc market cap and net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2026 | 85.5% | $29.71 Million | $34.75 Million | $5.05 Million | ▲ +14.2 pp |
| 2025 | 71.3% | $15.44 Million | $21.66 Million | $6.22 Million | ▲ +11.0 pp |
| 2024 | 60.2% | $13.93 Million | $23.13 Million | $9.20 Million | ▲ +10.5 pp |
| 2023 | 49.7% | $14.69 Million | $29.55 Million | $14.86 Million | ▲ +0.7 pp |
| 2022 | 49.0% | $16.42 Million | $33.55 Million | $17.12 Million | ▲ +2.8 pp |
| 2021 | 46.2% | $15.96 Million | $34.55 Million | $18.59 Million | ▲ +2.9 pp |
| 2020 | 43.3% | $9.40 Million | $21.70 Million | $12.30 Million | ▼ -20.3 pp |
| 2019 | 63.6% | $11.11 Million | $17.47 Million | $6.36 Million | ▲ +20.7 pp |
| 2018 | 42.9% | $3.29 Million | $7.66 Million | $4.37 Million | ▲ +8.8 pp |
| 2017 | 34.1% | $1.85 Million | $5.43 Million | $3.58 Million | ▲ +22.3 pp |
| 2016 | 11.8% | $742.77K | $6.30 Million | $5.55 Million | — |